Ausdal Financial Partners’s iShares Biotechnology ETF IBB Stock Holding History

Ausdal Financial Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$231K	Buy	1,369 +122	+10%	+$20.9K	0.01%	882
2025 Q4	$210K	Buy	+1,247	New	+$203K	0.01%	879
2023 Q4	–	Sell	-35,271	Closed	-$4.31M	–	462
2023 Q3	$4.31M	Buy	+35,271	New	+$4.49M	0.59%	33
2018 Q4	–	Sell	-2,043	Closed	-$249K	–	312
2018 Q3	$249K	Buy	2,043 +47	+2%	+$5.54K	0.07%	316
2018 Q2	$219K	Buy	+1,996	New	+$213K	0.07%	342
2018 Q1	–	Sell	-2,099	Closed	-$224K	–	374
2017 Q4	$224K	Buy	2,099 +29	+1%	+$3.1K	0.08%	310
2017 Q3	$230K	Buy	2,070 +87	+4%	+$9.3K	0.09%	286
2017 Q2	$205K	Buy	+1,983	New	+$195K	0.09%	282
2017 Q1	–	Sell	-2,613	Closed	-$231K	–	292
2016 Q4	$231K	Buy	+2,613	New	+$238K	0.11%	215
2016 Q1	–	Sell	-1,071	Closed	-$121K	–	589
2015 Q4	$121K	Buy	+1,071	New	+$116K	0.06%	272

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ausdal Financial Partners's IBB Position: Q1 2026 in Review

Ausdal Financial Partners increased its iShares Biotechnology ETF (IBB) stake by 9.8% in Q1 2026, buying an estimated $20.9K and bringing the position to 1,369 shares worth $231K. The position accounts for 0.01% of the portfolio, ranked #882.

Ausdal Financial Partners first reported a position in IBB in Q4 2015 and has held it in 10 quarters since. The position peaked at $4.31M in Q3 2023. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Ausdal Financial Partners held 1,369 shares of iShares Biotechnology ETF worth $231K as of Q1 2026.
Ausdal Financial Partners bought 122 iShares Biotechnology ETF shares in Q1 2026, an estimated $20.9K.
iShares Biotechnology ETF made up 0.01% of Ausdal Financial Partners's portfolio in Q1 2026, its #882 holding.
Ausdal Financial Partners first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 10 quarters since.
Ausdal Financial Partners's iShares Biotechnology ETF position peaked at $4.31M in Q3 2023.
919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Ausdal Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.